Future of medicine by Mischenko, Y.
МІНІСТЕРСТВО ОСВІТИ І НАУКИ УКРАЇНИ 
СУМСЬКИЙ ДЕРЖАВНИЙ УНІВЕРСИТЕТ 
КАФЕДРА ІНОЗЕМНИХ МОВ 
ЛІНГВІСТИЧНИЙ НАВЧАЛЬНО-МЕТОДИЧНИЙ 
ЦЕНТР 
 
 
 
 
 
 
МАТЕРІАЛИ 
Х ВСЕУКРАЇНСЬКОЇ НАУКОВО-ПРАКТИЧНОЇ 
КОНФЕРЕНЦІЇ СТУДЕНТІВ, АСПІРАНТІВ ТА 
ВИКЛАДАЧІВ 
ЛІНГВІСТИЧНОГО НАВЧАЛЬНО-МЕТОДИЧНОГО 
ЦЕНТРУ КАФЕДРИ ІНОЗЕМНИХ МОВ 
 
 
 
“WITH FOREIGN LANGUAGES TO MUTUAL 
UNDERSTANDING, BETTER TECHNOLOGIES AND 
ECOLOGICALLY SAFER ENVIRONMENT” 
 
 
 
 
 
 
 
(Суми, 24 березня 2016 року) 
The tenth all Ukrainian scientific practical student`s, 
postgraduate’s and teacher’s conference 
 
 
 
61 
 
FUTURE OF MEDICINE 
Y.Mischenko – Sumy State University, group IT – 51 
A.M.Diadechko, E L Adviser 
 
Medicine is the science and practice of the diagnosis, 
treatment and prevention of disease. For the last years medicine has 
evolved greatly. And many new achievements have appeared. 
Health Watch, house call is back. Doctors can already gather 
your glucose from their gardens and check your liver from the links. 
Remote medical monitoring will be commonplace in the future and it 
promises to benefit both physicians and patients by saving time and 
money. 
Imagine a world where there is no donor organ shortage. 
Where victims of spinal cord injuries can walk, where weakened 
hearts are replaced. This is the long-term promise of regenerative 
medicine, a rapidly developing field with the potential to transform 
the treatment of human disease through the development of 
innovative new therapies that offer a faster, more complete recovery 
with significantly fewer side effects or risk of complications. 
 Pandemic research, Influenza viruses are classified as type A, 
B, or C based upon their protein composition. Type A viruses are 
found in many kinds of animals, including ducks, chickens, pigs, 
whales, and also in humans.The type B virus widely circulates in 
humans. Type C has been found in humans, pigs, and dogs and 
causes mild respiratory infections, but does not spark epidemics. 
Type A influenza is the most frightening of the three. It is believed 
responsible for the global outbreaks of 1918, 1957 and 1968. 
Nanomedicine is promising great things, including great 
advancements in the treatment of cancer. Imagine swarms of 
nanobots swimming through your veins, repairing cells or attacking 
viruses. On second thought, get that image out of your mind, it's a bit 
creepy. Just close your eyes and wait for the healing to begin. 
Organ printing printable organ is an artificially constructed 
device designed for organ replacement, produced using 3D printing 
techniques. The primary purpose of printable organs is in 
transplantation. Research is currently being conducted on artificial 
heart, kidney, and liverstructures, as well as other major organs. For 
more complicated organs, such as the heart, smaller constructs such 
as heart valves have also been the subject of research. Some printed 
organs have already reached clinical implementation, and primarily 
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include hollow structures such as the bladder, as well as vascular 
structures such as urine tubes. 
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New life requirements enforce doctors navigate one of the 
most important scientific questions faced by the cancer community 
could help improve survival rates for patients. A joint initiative of 
UNICANCER, ESMO and Cancer Research UK, the meeting on 
Molecular Analysis for Personalised therapy (MAP) will explore 
clinical interpretation of molecular tests for cancers that have spread. 
By learning more about their patients' genetic makeup, 
doctors hope to develop more effective and customised strategies for 
prevention, screening and therapy. In addition, these techniques 
strive to lower treatment side effects.  
The development of new biotechnologies has revolutionised 
the applications of personalised therapy in advanced cancer that has 
spread. 
It is now possible to perform multigene sequencing for cancer 
patients, either in clinical trials or in routine use, and the knowledge 
gained will help clinicians prescribe therapies specifically adapted 
for each individual patient's case, which could reduce overall 
treatment costs and ultimately provide better care. 
Co-founder Pr Fabrice André of the Gustave Roussy Institute 
in Villejuif, explained why the programme of this new meeting was 
so vital, helping medical oncologists translate latest clinical research 
into applicable medical treatment approaches. 
The results of genomic research have already yielded results 
for new cancer therapies. Because each person‘s sequencing may 
show a myriad of mutations, may of which may be rare or unique, 
precision cancer medicine is a highly complex process, explained 
Cofounder Pr Charles Swanton, Cancer research UK scientist based 
at the Francis Crick Institute. 
 
